 NEW YORK, Nov. 23, 2022 GLOBE NEWSWIRE -- Axsome Therapeutics, Inc. NASDAQ: AXSM, a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system CNS disorders, today announced that Herriot Tabuteau, MD, Axsomes Chief Executive Officer, will participate in a virtual fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022 at 12:10 PM Eastern Time. 